Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
KogoPAY is a start-up fintech mobile payment company which offers quick, simple and economic regional & global money transfer with the help of an application. The company has a UK FCA licence, and it is on the last step for EU EMI licence. KogoPay has 1000 customers signed up and has been chosen to join the Mayor of London Business & Partners Accelerator. The company is planning to use the funds to complete rollout over Europe and Asia and to invest in advanced performance and customer service using Artificial Intelligence.
days to go:
Expired
investment:
£198,620
Equipsme is a company that aims to democratise health insurance by making it affordable for businesses. The company offers flexible fixed-price packages to employees while giving them the option to upgrade their package to avail more features upon payment. Members can speak to a general physician round the clock, have physiotherapy sessions, avail regular health checks and, if necessary, be quickly referred to a consultant for diagnosis and treatment. Members can access these features through a simple-to-use application. Since February 2018, the company has secured an exclusive 5-year insurance capacity deal with AXA PPP Healthcare and grown its members by 130.5% Year-on-Year (YoY) (to May 2020) with a 95% broker renewal retention rate. The company will use the investment to enhance its user experience and scale its marketing as it announces its partnerships with organisations such as Starling Bank and Simply Business.
days to go:
Expired
investment:
£879,204
TimeToTrade is an online trading platform which gives every investor access to advanced trading technologies. TimeToTrade aims to make investing easier. They currently have 31,000 registered users that are making over 500,000 trading signals every month.
days to go:
Expired
investment:
£146,480
EasyGym operates an international, low-cost, fast-growing, big-box gym franchise network. While working with 6 countries and more than 250 sites, easyGym is growing rapidly with its franchise system and cloud-based technology. It is aiming to provide people with access to high-quality gyms that are open 24/7. The company aims to use its recurring revenue to develop a sustainable business platform capable to drive innovation, generate investment value, and support global expansion. With the proceeds, easyGym will build the biggest global fitness network by 2030. 50% of its proceeds will be used to create a corporate hub in London, 17% will be used in Franchise Marketing, and 33% will be used for Technology and Support.
days to go:
Expired
investment:
£828,357
Nova launches growth focus, tech-enabled startups, putting passionate founders at the heart of everything they do. It creates a more rewarding experience for startups with its co-founding model. The company conceives and scales digital businesses thereby solving the real-world problems, open new markets and disrupt existing ones. 46% of Nova co-founded businesses are still trading. There are 140+ staff over Manchester, Liverpool, London, and Islamabad. There is a 3% portfolio valuation growth YOY, thereby creating more than £72m valuation of the portfolio. The company made a turnover of £7.2m in 2018/19. Nova is raising funds to leverage the company's growing network of Founders, Funds, and Talent in the UK.
days to go:
Expired
investment:
£744,880
A financial management software application for consumers to view everything from credit files and bank accounts, to vouchers and cashbacks. Score Genius aims to launch an Alpha version of their product at the end of 2018, with a public release planned for March 2019. The service will offer users the ability to monitor their credit files and perform transactions on their bank accounts and credits, as Open Banking will be integrated into the platform.
Score Genius is near completion of negotiations with large technological partners. Investments will used to market the platform and further develop features and functions, ready for the public release in 2019. Revenue streams will be comprised of advertisements, redeeming vouchers and users looking to switch their energy.
days to go:
Expired
investment:
£144,920
